Loading patent…
AssigneeSecretary of Agency of Industrial Science and Technology
InventorsManami Tanaka, Tomoo Tanaka
Estimating the term…
A human-derived bradeion protein, which has the following properties: (i) it is a transmembranous protein; (ii) it has a structure characteristic of growth hormone and cytokine receptors even in a structure of its transmembranous portion when its structure is determined by a hydrophobicity analysis according to Kyte-Doolittle method; (iii) it is expressed at a high level in a human adult brain, and in less amount in the heart, while it is not expressed in other adult organs or fetus; (iv) it induces programmed cell death (apoptosis) when over-expressed in a cultured human nerve cell lines; (v) it induces termination of cell division and aging when over-expressed in a cultured human normal cell; (vi) it is located in cytoplasm, and forms an intracellular aggregate when overexpressed; and (vii) besides human adult neurons, it is specifically expressed in a human colorectal cancer cell line or in a skin cancer cell line, or an analogue thereof.
A human-derived bradeion protein, which has the following properties:
A vector comprising the isolated DNA according to claim 17.
An isolated DNA that encodes a protein characterized by at least 90% homology with a human-derived bradeion a protein that (A) comprises an amino acid sequence of SEQ ID NO:2 and (B) has the following properties:
Dependencies are inferred from the claim text.